ISS ESG has voluntarily issued an Environmental, Social and Governance (ESG) Corporate Rating Report to Mankind Pharma on June 3, 2025. As per the report, the Company has been assigned an overall ESG score of 38.98 (Rating: C-). The company has not verified any data on which this rating has been issued.
Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1619.80 |
| Dr. Reddys Lab | 1328.05 |
| Cipla | 1288.80 |
| Zydus Lifesciences | 930.20 |
| Lupin | 2269.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: